Actio & Atrion International Launch REACHtracker(TM)
* Reuters is not responsible for the content in this press release.
SaaS solution facilitates identification and management of supplier substance pre-registration and registration intentions under REACH legislation BOSTON, April 24 /PRNewswire/ -- Actio in partnership with Atrion International today announced the availability of REACHtracker(TM), a SaaS solution for managing supply chain communication and substance inventory for pre-registration and registration obligations under Europe's new REACH legislation. REACHtracker(TM) enables companies to initiate supply chain cooperation by leveraging structured e-mail communications and secure on-line questionnaires that facilitate the otherwise complex, time-consuming process of gathering and managing supplier substance registration intentions-the critical first step towards REACH compliance. "REACH poses significant supply chain risk for companies selling products and raw materials into and within the EU," stated Russ McCann, Actio's President. "If a company is unaware of the registration status of their raw materials, they could face manufacturing disruption or worse, prohibition. REACHtracker(TM) eliminates this risk by providing a collaborative environment to capture substance data and REACH intentions, on an ongoing basis, throughout the supply chain." REACHtracker(TM) enables companies to build email campaigns that direct suppliers to enter substance information and declare their REACH registration intentions via a secure on-line questionnaire that links directly into a substance information management database. The progress of each supplier can be tracked and follow-up e-mail campaigns can be conducted for non-responsive suppliers. REACHtracker(TM) also provides a dashboard to manage supplier contact information, as well as sophisticated parametric reporting tools that enable data to be rolled up into an unlimited number of custom reports. Once all substance information is collected, REACHtracker(TM) automatically generates and uploads pre-registration XML files. "Atrion is very pleased to have been able to continue the collaborative nature of our partnership with Actio," said Patrick Lavoie, President at Atrion. "By providing Atrion's regulatory insight and market validation, REACHtracker(TM) is a viable REACH solution for companies facing the complexities of the European Union's REACH Legislation." REACHtracker(TM) fully supports Verisign's Secure Socket Layer (SSL) to ensure security of data flow throughout the supply chain. The solution is also fully integrated with Actio's Chemical Management Solutions enabling the automatic pre-screening and authorization of new chemicals, (M)SDS management, inventory tracking using ERP systems, storage and dissemination of raw material information. REACHtracker(TM) is currently available in both the North American and European Union and is co-marketed by both Actio and Atrion International. About REACH REACH is a substance-based regulation which mandates that every substance used in the manufacture of an article or preparation needs be identified and assessed. If greater than one ton is purchased or used, then the material must be registered with the European Chemicals Agency (ECHA). REACH obligations correlate directly to a company's REACH role within the supply chain. Typically a substance manufacturer would register the chemical so the downstream users can continue to use the substances in their products. If for example, a supplier chooses not to register a particular substance, then the downstream customer must either register the substance itself or discontinue use of the substance. The deadline for pre-registration is December 1st 2008. About Actio Corporation Since 1996, Actio has been helping companies and millions of their employees, in a wide range of industries, cost-effectively manage the complexities surrounding the use of chemicals in the global workplace. Actio is a leading provider of chemical management solutions delivered as SaaS (software as a service). Our chemical management portfolio manages all phases of the chemical life cycle, enabling corporations to utilize Six Sigma or a "best practices" approach for chemical management. Actio solutions track raw material chemical composition for compliance with global regulations including: REACH, RoHS, WEEE. For more information about Actio Corporation, visit www.actiocms.com About Atrion Atrion International Inc., founded in 1989, delivers the most reliable and dependable product compliance solutions for multi-national 'formula-based' companies. Compared to other solutions, Atrion integrates the largest set of 'expert' regulatory content into a proven & pre-packaged automation solution. Able to 'connect' to key ERP systems, Atrion's material compliance solution delivers the peace of mind that products will reach customers, with minimal risks to brand image and shareholder value. Additionally, Atrion and its certified SAP(R) partners provide a robust solution which compliments SAP's REACH offering. Atrion International is a global software company headquartered in Montreal, Quebec, Canada with offices in the United States, Europe and Asia Pacific. MSDS VAULT, ACTIO REGULATOR and INTELLIGENTEXT are registered trademarks of Actio Corporation. MSDSXCHANGE, ACTIO GATEKEEPER, MSDS VAULT LABELMAKER and MATERIAL DISCLOSURE.COM, HAPtracker and REACHtracker are trademarks of Actio Corporation 2008. All Rights Reserved. All other trademarks are the property of their respective owners. SOURCE Actio Corporation Chris Nowak, Director of Business Development of Actio, +1-603-433-2300 ext. 150, email@example.com; or Donna Zamiska, Marketing & Communication Manager of Atrion Intl., +1-514-337-2114, ext. 226, firstname.lastname@example.org; or PR Contact, Sabine Kerner of IFact, Inc., +1-514-735-9892, email@example.com, for Actio Corporation
- Washington wins diplomatic support for campaign in Iraq; Syria trickier |
- Apple iPhone 6 pre-orders hit record 4 million on first day |
- Western sanctions are testing Russia's strength: Medvedev |
- Alibaba worried about Facebook IPO as considered Nasdaq versus NYSE |
- Exclusive: Two Apple medical trials shed light on how HealthKit will work